The Molecular Atlas / Copper peptides
By Dissolv Labs · Published October 13, 2026 · Selected sources checked October 13, 2026
The direct answer
AHK-Cu and GHK-Cu are different copper-binding tripeptides. AHK contains alanine–histidine–lysine; GHK contains glycine–histidine–lysine. Their similar names do not make their experiments or product formulations interchangeable.
Evidence lens: Laboratory and animal studies
Start with the first letter
In peptide shorthand, A represents alanine and G represents glycine. H and K represent histidine and lysine. Both names here include Cu for copper, but the first amino-acid residue differs. Similarity can suggest a research question; it cannot answer whether the two compounds behave identically in a particular system.
AHK-Cu: what “human hair” meant in the study
A 2007 experiment examined isolated human hair follicles outside the body and cultured dermal papilla cells. Researchers reported follicle elongation and cell proliferation under the tested conditions. Crucially, these were ex vivo and in vitro experiments, not a trial that assigned people a hair product and measured scalp outcomes. The reported reduction in the number of apoptotic cells was not statistically significant, even though other molecular measures changed. See Pyo and colleagues' original paper.
That detail is a useful lesson in reading abstracts. A paper can contain several measurements with different strengths of evidence. Compressing all of them into “proven hair growth” removes both the experimental setting and the uncertainty.
GHK-Cu: a different experiment answers a different question
A 1993 GHK-Cu study investigated connective-tissue accumulation in experimental wound chambers in rats. Its tissue and biochemical findings belong to that model. They are not a head-to-head comparison against AHK-Cu and do not establish how a particular face cream performs in people. Read the rat wound-model study.
How to compare copper-peptide claims fairly
Build the comparison around three matches. First, match the sequence and copper complex. Second, match the model: isolated tissue, cultured cells, animals or participants. Third, match the outcome. Follicle elongation, a gene-expression change and a visible cosmetic result are different observations.
For example, “tested in human-derived cells” is a precise description of a laboratory model. “Clinically tested” would suggest something different. The word human in a title or database filter does not settle that distinction; read the methods.
Also ask whether the study used the finished product being sold. Ingredient literature can explain why a formulator is interested in a molecule. It cannot fill in unknowns about concentration, formulation, stability, delivery or the outcome measured for that finished product.
A research vial and a cosmetic are separate comparisons
A named research material and a multi-ingredient balm serve different purposes and come with different documentation. Do not treat a research vial as an ingredient to add to a home formulation. For cosmetics, read the full ingredient list and the evidence for the actual formula. For research materials, read the identity and lot-specific analytical information. Neither category should borrow the other category's claims.
The most useful conclusion is therefore specific: these two copper peptides have distinct sequences, and the cited studies investigate different questions. A ranking such as “stronger” needs a defined endpoint and a suitable direct comparison; the two papers above do not provide one.
Knowledge check: Does a study of isolated human hair follicles count as a clinical trial?
No. Human-derived tissue can be studied outside the body. A clinical trial studies participants under a defined protocol.
Keep exploring
Sources and scope
Educational synthesis of selected sources, prepared with AI assistance. This is not a systematic review or independent medical review. Product links are to Dissolv Labs’ own catalog. For corrections, contact Dissolv Labs and include the source and passage.
